These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35987190)

  • 1. A possible covalent xanthine oxidase inhibitor TS10: Inhibition mechanism, metabolites identification and PDPK assessment.
    Zhang TJ; Zhang X; Xu EY; Wang ZR; Zhang ZH; Wang QY; Wang L; Wen YQ; Meng FH
    Bioorg Chem; 2022 Nov; 128():106064. PubMed ID: 35987190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amide-based xanthine oxidase inhibitors bearing an N-(1-alkyl-3-cyano-1H-indol-5-yl) moiety: Design, synthesis and structure-activity relationship investigation.
    Zhang TJ; Tu S; Zhang X; Wang QY; Hu SS; Zhang Y; Zhang ZH; Wang ZR; Meng FH
    Bioorg Chem; 2021 Dec; 117():105417. PubMed ID: 34673452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors.
    Zhang TJ; Zhang Y; Tu S; Wu YH; Zhang ZH; Meng FH
    Eur J Med Chem; 2019 Dec; 183():111717. PubMed ID: 31557611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of N-(4-alkoxy-3-(1H-tetrazol-1-yl)phenyl) heterocyclic aromatic amide derivatives as xanthine oxidase inhibitors.
    Zhang TJ; Zhang ZH; Zhang X; Wang ZR; Xu EY; Tu S; Zhang Y; Meng FH
    Bioorg Chem; 2022 Oct; 127():105938. PubMed ID: 35752100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
    Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation.
    Gao J; Zhang Z; Zhang B; Mao Q; Dai X; Zou Q; Lei Y; Feng Y; Wang S
    Bioorg Chem; 2020 Jan; 95():103564. PubMed ID: 31927335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
    Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
    Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3,4-Dihydroxy-5-nitrobenzaldehyde (DHNB) is a potent inhibitor of xanthine oxidase: a potential therapeutic agent for treatment of hyperuricemia and gout.
    Lü JM; Yao Q; Chen C
    Biochem Pharmacol; 2013 Nov; 86(9):1328-37. PubMed ID: 23994369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(3-cyano-1H-indol-5-yl)isonicotinamide and N-(3-cyano-1H-indol-5-yl)-1H-benzo[d]imidazole-5-carboxamide derivatives: Novel amide-based xanthine oxidase inhibitors.
    Tu S; Zhang TJ; Zhang Y; Zhang X; Zhang ZH; Meng FH
    Bioorg Chem; 2021 Oct; 115():105181. PubMed ID: 34329991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
    Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
    Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors.
    Hu SS; Zhang TJ; Wang ZR; Xu EY; Wang QY; Zhang X; Guo S; Ge GH; Wang J; Meng FH
    Bioorg Chem; 2023 Apr; 133():106403. PubMed ID: 36801790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of 5-benzyl-3-pyridyl-1H-1,2,4-triazole Derivatives as Xanthine Oxidase Inhibitors.
    Li SY; Zhang TJ; Wu QX; Olounfeh KM; Zhang Y; Meng FH
    Med Chem; 2020; 16(1):119-127. PubMed ID: 30963981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of derivatives from Spartina alterniflora-sourced moiety as xanthine oxidase inhibitors to lower uric acid.
    Yang YS; Wang B; Zhou KM; Liu J; Jiao QC; Qin P
    Bioorg Med Chem Lett; 2022 Oct; 73():128907. PubMed ID: 35902063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.
    Chu WY; Annink KV; Nijstad AL; Maiwald CA; Schroth M; Bakkali LE; van Bel F; Benders MJNL; van Weissenbruch MM; Hagen A; Franz AR; Dorlo TPC; Allegaert K; Huitema ADR;
    Clin Pharmacokinet; 2022 Feb; 61(2):321-333. PubMed ID: 34617261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction.
    Yang C; Liu Y; Tu Y; Li L; Du J; Yu D; He P; Wang T; Liu Y; Chen H; Li Y
    Bioorg Chem; 2023 Feb; 131():106320. PubMed ID: 36527991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies.
    Di Petrillo A; Siguri C; Delogu GL; Fais A; Era B; Floris S; Pintus F; Kumar A; Fantini MC; Olla S
    Chem Biol Interact; 2024 Jul; 397():111087. PubMed ID: 38823536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Xanthine Oxidase by 4-nitrocinnamic Acid:
    Chen J; Yu S; He Z; Zhu D; Cai X; Ruan Z; Jin N
    Curr Pharm Biotechnol; 2024; 25(4):477-487. PubMed ID: 37345239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors.
    Zhao J; Mao Q; Lin F; Zhang B; Sun M; Zhang T; Wang S
    Eur J Med Chem; 2022 Feb; 229():114086. PubMed ID: 34992040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new sensitive and quantitative chemiluminescent assay to monitor intracellular xanthine oxidase activity for rapid screening of inhibitors in living endothelial cells.
    Caliceti C; Calabria D; Roda A
    Anal Bioanal Chem; 2016 Dec; 408(30):8755-8760. PubMed ID: 27392750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the interaction mechanism between luteoloside and xanthine oxidase by multi-spectroscopic and molecular docking methods.
    Chen J; Wang Y; Pan X; Cheng Y; Liu J; Cao X
    J Mol Recognit; 2022 Dec; 35(12):e2985. PubMed ID: 35907782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.